PREOPERATIVE AND POSTOPERATIVE EVALUATION OF PROSTATE-SPECIFIC ANTIGEN IN LOCALIZED PROSTATIC-CANCER TREATED BY RADICAL PROSTATECTOMY

被引:0
|
作者
ZATTONI, F
PIAZZA, R
VIANELLO, R
GARBEGLIO, A
PAGANO, F
机构
关键词
PROSTATIC CARCINOMA; PROSTATE-SPECIFIC ANTIGEN; RADICAL PROSTATECTOMY;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Preoperative prostate-specific antigen (PSA) values were determined in 73 patients with clinically localized prostatic cancer and candidates for a radical procedure. Correlation of preoperative PSA with a final pathological stage was attempted. Only i n 44.8% of our 22 patients with organ-confined disease was the PSA value within the normal range; in 17.3% of cases PSA values were higher than 20 ng/ml. 18.2% of the patients with locally advanced disease showed normal PSA values, while 45.5% had concentrations above 20 ng/ml. In the case of lymph node involvement, PSA values were normal in 22.7% of the cases. Our data indicate that no strict relationship can be suggested between PSA and the final pathological stage and grading of the tumor in patients who underwent radical prostatectomy.
引用
收藏
页码:99 / 101
页数:3
相关论文
共 50 条
  • [21] CLINICAL USEFULNESS OF PROSTATE-SPECIFIC ANTIGEN AND PROSTATIC ACID-PHOSPHATASE IN PATIENTS WITH PROSTATIC-CANCER
    FILELLA, X
    MOLINA, R
    JO, J
    UMBERT, B
    BEDINI, JL
    BALLESTA, AM
    TUMOR BIOLOGY, 1990, 11 (06) : 289 - 294
  • [22] Re: Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
    Shteynshlyuger, Alex
    Kibel, Adam S.
    EUROPEAN UROLOGY, 2009, 56 (06) : 1089 - 1090
  • [23] PREOPERATIVE PROSTATE-SPECIFIC ANTIGEN IN PREDICTING PATHOLOGICAL STAGE AND GRADE AFTER RADICAL PROSTATECTOMY
    WINTER, HI
    BRETTON, PR
    HERR, HW
    UROLOGY, 1991, 38 (03) : 202 - 205
  • [24] PROSTATE-SPECIFIC ANTIGEN PROGRESSION RATES AFTER RADICAL PROSTATECTOMY OR RADIATION-THERAPY FOR LOCALIZED PROSTATE-CANCER
    FOWLER, JE
    PANDEY, P
    BRASWELL, NT
    SEAVER, L
    SURGERY, 1994, 116 (02) : 302 - 306
  • [25] The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml
    C Bastide
    R Kuefer
    M Loeffler
    R de Petriconi
    J Gschwend
    R Hautmann
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 239 - 244
  • [26] Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer
    Ronquist, Gunnar
    Frithz, Goran
    Wang, Yu-Hui
    Lindeborg, Torsten
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2009, 43 (01): : 32 - 36
  • [27] 10-Year Mortality After Radical Prostatectomy for Localized Prostate Cancer in the Prostate-specific Antigen Screening Era
    Mendhiratta, Neil
    Lee, Ted
    Prabhu, Vinay
    Llukani, Elton
    Lepor, Herbert
    UROLOGY, 2015, 86 (04) : 783 - 788
  • [28] Early prostate-specific antigen relapse after radical retropubic prostatectomy: Prediction on the basis of preoperative and postoperative tumor characteristics
    Graefen, M
    Noldus, J
    Pichlmeier, U
    Haese, A
    Hammerer, P
    Fernandez, S
    Conrad, S
    Henke, RP
    Huland, E
    Huland, H
    EUROPEAN UROLOGY, 1999, 36 (01) : 21 - 30
  • [29] EVALUATION OF PROSTATE SPECIFIC ACID-PHOSPHATASE AND PROSTATE SPECIFIC ANTIGEN IN IDENTIFICATION OF PROSTATIC-CANCER
    ALLHOFF, EP
    PROPPE, KH
    CHAPMAN, CM
    LIN, CW
    PROUT, GR
    MOSTOFI, FK
    PONTES, JE
    JOURNAL OF UROLOGY, 1983, 129 (02): : 315 - 318
  • [30] Is there a prostate-specific antigen upper limit for radical prostatectomy?
    Gontero, Paulo
    Spahn, Martin
    Tombal, Bertrand
    Bader, Pia
    Hsu, Chao-Yu
    Marchioro, Giansilvio
    Frea, Bruno
    Van der Eeckt, Kathy
    Kneitz, Burkhard
    Frohneberg, Detlef
    Tizzani, Alessandro
    Van Poppel, Hendrik
    Joniau, Steven
    BJU INTERNATIONAL, 2011, 108 (07) : 1093 - 1100